We use cookies for a better user experience. Read our Privacy Policy

I Agree

Vascular Injury Treatment Market

Vascular Injury Treatment Market (Injury: Spasm, Thrombosis, Contusion/Intimal Flap, Laceration/Transection, Arteriovenous (AV) Fistula, Aneurysm & Pseudoaneurysm, and Others; Treatment: Lateral Arteriorrhaphy/ Venorrhaphy, Patch Angioplasty, Bypass Graft, Extraanatomic Bypass, Thrombectomy, and Others; End User: Hospitals, Ambulatory Surgical Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Growing Need for Extra-Anatomical Aortic Bypass Graft in Military and Emergency Cases

The most challenging vascular injuries involve trauma caused to the abdomen, pelvis, and retroperitoneal structures of the body. Complications such as difficulty in acquiring immediate proximal control & appropriate exposure, treatment of injury in face of contamination, and provisions for prolonged surveillance & follow-up have increased the need for vascular injury treatment.

Vascular injuries can occur in civilian as well as military setting. Traumatic vascular injury caused due to explosions and projectiles such as bullets and shrapnel severely affect the arteries and veins of the limbs, and trigger excessive blood loss and ischemia. Thus, there is the constant need for instant relief and effective treatment solutions for vascular injuries in military and emergency cases.

As such, healthcare providers in the vascular injury treatment landscape are adopting the extra-anatomical aortic bypass graft to solve grave vascular injuries in military and emergency cases. Adequately-sized interposition grafts help in the successful management and repair of damaged tissues and other serious vascular injuries.

vascular injury treatment market infographic

To know the scope of our report Get a Sample on Vascular Injury Treatment Market

Preventive Measures Help Reduce Arterial Thromboembolic Incidences

Growing incidences of anticancer drug induced arterial injuries are surfacing in the vascular injury treatment ecosystem. The side effects of chemotherapeutic drugs and anti-tumor medicines complicate treatment cycles. These side effects are some of the causes for the increase in non-cancer-related mortality rates, and affect the quality of life of cancer survivors. Growing incidences of arterial thromboembolic events (ATEE) are also associated with the consumption of anti-cancer drugs.

As such, stakeholders need to develop treatment solutions to assess the high risks of vascular complications, and innovate on antithrombotic therapies that keep a tab on thromboembolic and bleeding risks. Preventive measures and individualized chemotherapy serve as viable treatment steps to reduce the incidences of anti-tumor treatment-related vascular events. As such, ongoing research and development is being carried out to address ATEE risk stratification, which helps in early prediction and reduced complications in cancer survivors.

Get a glimpse of the in-depth analysis through our Report Brochure

Improvements in Trauma Care: Need of the Hour for Firearm Injuries

A recent study on vascular injury treatment, conducted by researchers from the Boston University School of Medicine (BUSM), stated that, individuals who suffered firearm injuries and underwent surgical repair of major blood vessels were more susceptible to the high injury severity score (a scale made to predict in-hospital deaths).

In many cases, individuals that suffer firearm injuries due to gunshots undergo vascular injury treatment to repair the damage caused by bullets to major blood vessels. After several cross-validations, it found that, individuals who underwent surgical repair of their major blood vessels accounted for a high injury severity score as compared to those who didn’t undergo surgical repair treatment. Further studies showed that, the risk of death increased by five times, and complications increased three times, due to surgical repair treatment.

Complications such as venous thromboembolism, kidney failure, sepsis, and heart and neurologic-related complexes were greater in patients who underwent repair of their major blood vessels. Thus, stakeholders in the vascular injury treatment landscape need to carry out clinical trials to better understand firearm injuries and the impact of surgical repair on major blood vessels. Improvements in trauma care can help emergency medicine physicians and vascular injury treatment surgeons develop efficient treatment solutions for gun violence survivors.

vascular injury treatment market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

Analysts of the vascular injury treatment market have a promising outlook for its growth potential during the forecast period of 2019-2027. Stakeholders in the landscape are developing innovative offerings for bypass graft and lateral arteriorrhaphy treatment solutions. Increasing incidences of firearm injuries and arterial thromboembolic events in cancer patients have influenced the need for efficacious vascular injury treatment solutions. However, there is the need to improvise on the surgical repair treatment of major blood vessels for firearm injuries to avoid complications. Stakeholders in the vascular injury treatment landscape are developing preventive measures to reduce incidences of arterial thromboembolic events and improving trauma care for firearm injuries. Since bypass graft treatment accounts for a market share of ~34% in the vascular injury treatment landscape, stakeholders need to innovate on allograft repair treatment, as adequate frequency of follow-ups have resulted in excellent outcomes for patients.

Vascular Injury Treatment Market: Overview

  • According to Transparency Market Research’s latest market report on the global vascular injury treatment market for the historical period of 2017–2018 and forecast period of 2019–2027, rise in the prevalence of vascular injuries is projected to boost the growth of the global vascular injury treatment market during the forecast period.
  • The global vascular injury treatment market is estimated to reach ~US$ 2.9 Bn in 2019. The vascular injury treatment market is anticipated to expand at a CAGR of ~6% from 2019 to 2027.

Rise in Prevalence of Vascular Injuries: Key Driver of Vascular Injury Treatment Market

  • The prevalence of vascular injuries is rising among the population due to accidents, falls, cuts, and dislocation of bones. Hence, trauma is considered to be a leading cause of vascular injury.
  • According to the National Trauma Databank, vascular injuries account for 1% to 2% of all injuries reported in trauma patients. Penetrating trauma is the leading cause of peripheral vascular injuries, and accounted for over 71% of all vascular injuries in 2018. Among penetrating vascular injuries, handguns are the major cause of penetrating injuries in the U.S., followed by stab wounds and shotguns.
  • An article published in the Journal of Evolution of Medical and Dental Science stated that, the prevalence of vascular trauma has increased in the last few decades, and vascular injuries accounted for nearly 3% of all civilian trauma cases.
  • According to the Journal of Emergency and Critical Care Medicine, in China, the annual death toll due to trauma has reached over 400,000, making it the fifth most common cause of death. Furthermore, economic development in China has led to an increase in number of car accidents, which is currently the most frequent cause of trauma. Other causes of trauma include falls, earthquakes, tsunamis, and violence. Increase in the incidence of trauma is likely to drive the vascular injury treatment market in the country.

Focus on Collaborations, Agreements, Partnerships, and Technological Advancements

  • Key players focus on technological advancements and also on collaborations & partnerships in the global vascular injury treatment market.
  • Increase in collaborations, agreements, and partnerships by these players, and rise in the adoption of technologically-advanced products are anticipated to drive the global vascular injury treatment market.
  • For instance, in October 2018, Eko announced a collaboration with Mayo Clinic to develop data-driven technology that helps detect heart diseases.
  • In September 2018, Hirslanden Clinique La Colline, a part of Mediclinic International, merged with Clinique Des Grangettes, to provide a comprehensive range of therapeutic and diagnostic services for patients.
  • In March 2016, Boston Scientific Corporation announced the continuation of a collaboration with Mayo Clinic. This enabled the company to stimulate the rapid development of medical devices to address unmet clinical needs.
  • On April 14, 2016, Apollo Life along with Jiyo launched a digital wellness platform in order to address employee health and well-being.
  • Technological advancements such as endovascular techniques, CT angiography, and magnetic resonance imagining (MRI) provide high sensitivity and specificity for the detection of vascular injuries.

Vascular Injury Treatment Market: High Cost of Treatment

  • Cost is a major factor influencing the selection of treatment of vascular injury.
  • Morbidity and obesity increase the risk of vascular injuries. These require longer hospital stay and the cost of hospital care is high.
  • The cost of hospitalization for vascular injuries is higher as compared to non-vascular injuries. For instance, the cost of hospitalization for vascular injuries is US$ 131,500 and that of non-vascular injuries is US$ 60,000.
  • Hence, high cost of treatment is likely to hamper the growth of the global vascular injury treatment market.

Global Vascular Injury Treatment Market: Competitive Landscape

  • This report profiles major players in the global vascular injury treatment market based on various attributes such as company overview, financial overview, treatments performed, business strategies, and recent developments.
  • Key players operating in the global vascular injury treatment market include
    • Cleveland Clinic
    • Apollo Hospitals Enterprise Ltd.
    • Massachusetts General Hospital
    • Heidelberg University Hospital
    • Royal Berkshire NHS Foundation Trust
    • Universal Health Services, Inc.
    • Tenet Healthcare
    • Mayo Clinic Health System
    • Mediclinic International
    • CHSPSC LLC
    • IHH Healthcare Berhad.

Global Vascular Injury Treatment Market: Key Developments

Key manufacturers in the global vascular injury treatment market are strengthening their overseas sales structure by expanding their production capacities. Other developments in the global vascular injury treatment market are listed below.

  • In April 2019, Mayo Clinic collaborated with Children’s Hospital Colorado to provide a solution for hypoplastic left heart syndrome.
  • In 2018, Universal Health Services acquired the Danshell Group, which includes 25 behavioral health facilities in the U.K. Moreover, the company acquired a 109-bed behavioral healthcare facility located in Gulfport, Mississippi.
  • In August 2015, Apollo Hospitals signed a collaboration agreement with the American College of Cardiology (ACC) to expand medical education in India.

Vascular Injury Treatment Market - Segmentation

This exclusive research report encompasses the technological advancements as well as recent trends in order to get a better perspective regarding the growth of the vascular injury treatment market. In order to help market participants get a precise market understanding, our analysts have segregated the vascular injury treatment market into key segments – injury, treatment, end user, and region. This study further offers information regarding the incremental opportunities present in the vascular injury treatment market during the forecast period. Key segments of the vascular injury treatment market are as mentioned below:

Injury

Spasm

Thrombosis

Contusion/Intimal Flap

Laceration/Transection

Arteriovenous (AV) Fistula

Aneurysm and Pseudoaneurysm

Others

Treatment

Lateral Arteriorrhaphy/Venorrhaphy

Extra Anatomic Bypass

Patch Angioplasty

Bypass Graft

Thrombectomy

Others

End User

Hospitals

Ambulatory Surgical Centers

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

 

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Vascular Injury Treatment Market 

4. Market Overview

    4.1. Introduction

        4.1.1. Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Vascular Injury Treatment Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

    5.1. Reimbursement Scenario

    5.2. Regulatory Scenario

    5.3. Technological Advancements

    5.4. Number of Vascular Injury Incidences, by Region, (2018)

        5.4.1. Penetrating Wounds

        5.4.2. Blunt Trauma

        5.4.3. Invasive Procedures

6. Global Vascular Injury Treatment Market Analysis and Forecast, by Injury 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Injury, 2017–2027

        6.3.1. Spasm

        6.3.2. Thrombosis

        6.3.3. Contusion/Intimal Flap

        6.3.4. Laceration/Transection

        6.3.5. Arteriovenous (AV) Fistula

        6.3.6. Aneurysm and Pseudoaneurysm

        6.3.7. Others

    6.4. Market Attractiveness, by Injury 

7. Global Vascular Injury Treatment Market Analysis and Forecast, by Treatment 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Treatment, 2017–2027

        7.3.1. Lateral Arteriorrhaphy/ Venorrhaphy

        7.3.2. Patch Angioplasty 

        7.3.3. Bypass Graft 

        7.3.4. Extraanatomic Bypass

        7.3.5. Thrombectomy 

        7.3.6. Others

    7.4. Market Attractiveness, by Treatment 

8. Global Vascular Injury Treatment Market Analysis and Forecast, by End User

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End User, 2017–2027

        8.3.1. Hospitals 

        8.3.2. Ambulatory Surgical Centers 

        8.3.3. Others

    8.4. Market Attractiveness, by End User

9. Global Vascular Injury Treatment Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Market Attractiveness, by Country/Region

10. North America Vascular Injury Treatment Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Injury, 2017–2027

        10.2.1. Spasm

        10.2.2. Thrombosis

        10.2.3. Contusion/Intimal Flap

        10.2.4. Laceration/Transection

        10.2.5. Arteriovenous (AV) Fistula

        10.2.6. Aneurysm and Pseudoaneurysm

        10.2.7. Others

    10.3. Market Value Forecast, by Treatment, 2017–2027

        10.3.1. Lateral Arteriorrhaphy/ Venorrhaphy

        10.3.2. Patch Angioplasty 

        10.3.3. Bypass Graft 

        10.3.4. Extraanatomic Bypass

        10.3.5. Thrombectomy 

        10.3.6. Others

    10.4. Market Value Forecast, by End User, 2017–2027

        10.4.1. Hospitals 

        10.4.2. Ambulatory Surgical Centers 

        10.4.3. Others

    10.5. Market Value Forecast, by Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis 

        10.6.1. By Injury 

        10.6.2. By Treatment 

        10.6.3. By End User

        10.6.4. By Country

11. Europe Vascular Injury Treatment Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Injury, 2017–2027

        11.2.1. Spasm

        11.2.2. Thrombosis

        11.2.3. Contusion/Intimal Flap

        11.2.4. Laceration/Transection

        11.2.5. Arteriovenous (AV) Fistula

        11.2.6. Aneurysm and Pseudoaneurysm

        11.2.7. Others

    11.3. Market Value Forecast, by Treatment, 2017–2027

        11.3.1. Lateral Arteriorrhaphy/ Venorrhaphy

        11.3.2. Patch Angioplasty 

        11.3.3. Bypass Graft 

        11.3.4. Extraanatomic Bypass

        11.3.5. Thrombectomy 

        11.3.6. Others

    11.4. Market Value Forecast, by End User, 2017–2027

        11.4.1. Hospitals 

        11.4.2. Ambulatory Surgical Centers 

        11.4.3. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis 

    11.6.1. By Injury 

    11.6.2. By Treatment 

    11.6.3. By End User

    11.6.4. By Country/Sub-region

12. Asia Pacific Vascular Injury Treatment Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Injury, 2017–2027

        12.2.1. Spasm

        12.2.2. Thrombosis

        12.2.3. Contusion/Intimal Flap

        12.2.4. Laceration/Transection

        12.2.5. Arteriovenous (AV) Fistula

        12.2.6. Aneurysm and Pseudoaneurysm

        12.2.7. Others

    12.3. Market Value Forecast, by Treatment, 2017–2027

        12.3.1. Lateral Arteriorrhaphy/ Venorrhaphy

        12.3.2. Patch Angioplasty 

        12.3.3. Bypass Graft 

        12.3.4. Extraanatomic Bypass

        12.3.5. Thrombectomy 

        12.3.6. Others

    12.4. Market Value Forecast, by End User, 2017–2027

        12.4.1. Hospitals 

        12.4.2. Ambulatory Surgical Centers 

        12.4.3. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis 

        12.6.1. By Injury 

        12.6.2. By Treatment 

        12.6.3. By End User

        12.6.4. By Country/Sub-region

13. Latin America Vascular Injury Treatment Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Injury, 2017–2027

        13.2.1. Spasm

        13.2.2. Thrombosis

        13.2.3. Contusion/Intimal Flap

        13.2.4. Laceration/Transection

        13.2.5. Arteriovenous (AV) Fistula

        13.2.6. Aneurysm and Pseudoaneurysm

        13.2.7. Others

    13.3. Market Value Forecast, by Treatment, 2017–2027

        13.3.1. Lateral Arteriorrhaphy/ Venorrhaphy

        13.3.2. Patch Angioplasty 

        13.3.3. Bypass Graft 

        13.3.4. Extraanatomic Bypass

        13.3.5. Thrombectomy 

        13.3.6. Others

    13.4. Market Value Forecast, by End User, 2017–2027

        13.4.1. Hospitals 

        13.4.2. Ambulatory Surgical Centers 

        13.4.3. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis 

        13.6.1. By Injury 

        13.6.2. By Treatment 

        13.6.3. By End User

        13.6.4. By Country/Sub-region

14. Middle East & Africa Vascular Injury Treatment Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Injury, 2017–2027

        14.2.1. Spasm

        14.2.2. Thrombosis

        14.2.3. Contusion/Intimal Flap

        14.2.4. Laceration/Transection

        14.2.5. Arteriovenous (AV) Fistula

        14.2.6. Aneurysm and Pseudoaneurysm

        14.2.7. Others

    14.3. Market Value Forecast, by Treatment, 2017–2027

        14.3.1. Lateral Arteriorrhaphy/ Venorrhaphy

        14.3.2. Patch Angioplasty 

        14.3.3. Bypass Graft 

        14.3.4. Extraanatomic Bypass

        14.3.5. Thrombectomy 

        14.3.6. Others

    14.4. Market Value Forecast, by End User, 2017–2027

        14.4.1. Hospitals 

        14.4.2. Ambulatory Surgical Centers 

        14.4.3. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis 

        14.6.1. By Injury 

        14.6.2. By Treatment 

        14.6.3. By End User

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Company Profiles

        15.1.1. Cleveland Clinic 

            15.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.1.2. Company Financials

            15.1.1.3. Growth Strategies

            15.1.1.4. SWOT Analysis

        15.1.2. Apollo Hospitals Enterprise Ltd.

            15.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.2.2. Company Financials

            15.1.2.3. Growth Strategies

            15.1.2.4. SWOT Analysis

        15.1.3. Massachusetts General Hospital

            15.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.3.2. Company Financials

            15.1.3.3. Growth Strategies

            15.1.3.4. SWOT Analysis

        15.1.4. Heidelberg University Hospital

            15.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.4.2. Company Financials

            15.1.4.3. Growth Strategies

            15.1.4.4. SWOT Analysis

        15.1.5. Royal Berkshire NHS Foundation Trust

            15.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.5.2. Company Financials

            15.1.5.3. Growth Strategies

            15.1.5.4. SWOT Analysis

        15.1.6. Universal Health Services, Inc.

            15.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.6.2. Company Financials

            15.1.6.3. Growth Strategies

            15.1.6.4. SWOT Analysis

        15.1.7. Tenet Healthcare

            15.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.7.2. Company Financials

            15.1.7.3. Growth Strategies

            15.1.7.4. SWOT Analysis

        15.1.8. Mayo Clinic Health System

            15.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.8.2. Company Financials

            15.1.8.3. Growth Strategies

            15.1.8.4. SWOT Analysis

        15.1.9. Mediclinic International

            15.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.9.2. Company Financials

            15.1.9.3. Growth Strategies

            15.1.9.4. SWOT Analysis

        15.1.10. CHSPSC, LLC

            15.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.10.2. Company Financials

            15.1.10.3. Growth Strategies

            15.1.10.4. SWOT Analysis

        15.1.11. IHH Healthcare Berhad

            15.1.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.11.2. Company Financials

            15.1.11.3. Growth Strategies

            15.1.11.4. SWOT Analysis

*Note: Financial details for companies that do not report this information in public domain might not be captured

List of Tables

Table 01: Number of Vascular Injury Incidences, by Region, 2018
Table 02: North America Number of Vascular Injury Incidences, 2018
Table 03: Europe America Number of Vascular Injury Incidences, 2018
Table 04: Asia Pacific Number of Vascular Injury Incidences, 2018
Table 05: Latin America Number of Vascular Injury Incidences, 2018
Table 06: Middle East & Africa Number of Vascular Injury Incidences, 2018
Table 07: Global Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Injury, 2017–2027
Table 08: Global Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 09: Global Vascular Injury Treatment Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 10: Global Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 11: North America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 12: North America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Injury, 2017–2027
Table 13: North America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 14: North America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 15: Europe Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Europe Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Injury, 2017–2027
Table 17: Europe Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 18: Europe Vascular Injury Treatment Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 19: Asia Pacific Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
Table 20: Asia Pacific Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Injury, 2017–2027
Table 21: Asia Pacific Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 22: Asia Pacific Vascular Injury Treatment Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 23: Latin America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Latin America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Injury, 2017–2027
Table 25: Latin America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 26: Latin America Vascular Injury Treatment Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 27: Middle East & Africa Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
Table 28: Middle East & Africa Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Injury, 2017–2027
Table 29: Middle East & Africa Vascular Injury Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 30: Middle East & Africa Vascular Injury Treatment Market Value (US$ Mn) Forecast, by End User, 2017?2027

List of Figures

Figure 01: Global Vascular Injury Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027
Figure 02: Global Vascular Injury Treatment Market Value (US$ Mn) Forecast, 2017–2027
Figure 03: Global Vascular Injury Treatment Market Value Share (%), by Injury, 2018
Figure 04: Global Vascular Injury Treatment Market Value Share (%), by Treatment, 2018
Figure 05: Global Vascular Injury Treatment Market Value Share (%), by End User, 2018
Figure 06: Global Vascular Injury Treatment Market Value Share (%), by Region, 2018
Figure 07: Global Vascular Injury Treatment Market Value Share (%), by Injury, 2018 and 2027
Figure 08: Global Vascular Injury Treatment Market Value (US$ Mn), by Spasm, 2017–2027
Figure 09: Global Vascular Injury Treatment Market Value (US$ Mn), by Thrombosis, 2017–2027
Figure 10: Global Vascular Injury Treatment Market Value (US$ Mn), by Contusion/Intimal Flap, 2017–2027
Figure 11: Global Vascular Injury Treatment Market Value (US$ Mn), by Laceration/Transection, 2017–2027
Figure 12: Global Vascular Injury Treatment Market Value (US$ Mn), by Arteriovenous (AV) Fistula, 2017–2027
Figure 13: Global Vascular Injury Treatment Market Value (US$ Mn), by Aneurysm & Pseudoaneurysm, 2017–2027
Figure 14: Global Vascular Injury Treatment Market Value (US$ Mn), by Others, 2017–2027
Figure 15: Global Vascular Injury Treatment Market Attractiveness, by Injury, 2019?2027
Figure 16: Global Vascular Injury Treatment Market Value Share (%), by Treatment, 2018 and 2027
Figure 17: Global Vascular Injury Treatment Market Attractiveness, by Treatment, 2019–2027
Figure 18: Global Vascular Injury Treatment Market Value (US$ Mn), by Lateral Arteriorrhaphy/Venorrhaphy, 2017–2027
Figure 19: Global Vascular Injury Treatment Market Value (US$ Mn), by Patch Angioplasty, 2017–2027
Figure 20: Global Vascular Injury Treatment Market Value (US$ Mn), by Bypass Graft, 2017–2027
Figure 21: Global Vascular Injury Treatment Market Value (US$ Mn), by Extraanatomic Bypass, 2017–2027
Figure 22: Global Vascular Injury Treatment Market Value (US$ Mn), by Thrombectomy, 2017–2027
Figure 23: Global Vascular Injury Treatment Market Value (US$ Mn), by Others, 2017–2027
Figure 24: Global Vascular Injury Treatment Market Value Share (%), by End User, 2018 and 2027
Figure 25: Global Vascular Injury Treatment Market Attractiveness, by End User, 2019–2027
Figure 26: Global Vascular Injury Treatment Market Value (US$ Mn), by Hospitals, 2017–2027
Figure 27: Global Vascular Injury Treatment Market Value (US$ Mn), by Ambulatory Surgical Centers, 2017–2027
Figure 28: Global Vascular Injury Treatment Market Value (US$ Mn), by Others, 2017–2027
Figure 29: Global Vascular Injury Treatment Market Value Share Analysis, by Region, 2018 and 2027
Figure 30: Global Vascular Injury Treatment Market Attractiveness Analysis, by Region, 2019–2027
Figure 31: North America Vascular Injury Treatment Market Value (US$ Mn), 2017–2027
Figure 32: North America Vascular Injury Treatment Market Value Share Analysis, by Country, 2018 and 2027
Figure 33: North America Vascular Injury Treatment Market Attractiveness Analysis, by Country, 2019–2027
Figure 34: North America Vascular Injury Treatment Market Value Share (%), by Injury, 2018 and 2027
Figure 35: North America Vascular Injury Treatment Market Attractiveness, by Injury, 2019–2027
Figure 36: North America Vascular Injury Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 37: North America Vascular Injury Treatment Market Attractiveness Analysis, by Treatment, 2019–2027
Figure 38: North America Vascular Injury Treatment Market Value Share (%), by End User, 2018 and 2027
Figure 39: North America Vascular Injury Treatment Market Attractiveness, by End User, 2019–2027
Figure 40: Europe Vascular Injury Treatment Market Value (US$ Mn) Forecast, 2017–2027
Figure 41: Europe Vascular Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 42: Europe Vascular Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 43: Europe Vascular Injury Treatment Market Value Share (%), by Injury, 2018 and 2027
Figure 44: Europe Vascular Injury Treatment Market Attractiveness, by Injury, 2019–2027
Figure 45: Europe Vascular Injury Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 46: Europe Vascular Injury Treatment Market Attractiveness Analysis, by Treatment, 2019–2027
Figure 47: Europe Vascular Injury Treatment Market Value Share (%), by End User, 2018 and 2027
Figure 48: Europe Vascular Injury Treatment Market Attractiveness, by End User, 2019–2027
Figure 49: Asia Pacific Vascular Injury Treatment Market Value (US$ Mn), 2017–2027
Figure 50: Asia Pacific Vascular Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 51: Asia Pacific Vascular Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 52: Asia Pacific Vascular Injury Treatment Market Value Share (%), by Injury, 2018 and 2027
Figure 53: Asia Pacific Vascular Injury Treatment Market Attractiveness, by Injury, 2019–2027
Figure 54: Asia Pacific Vascular Injury Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 55: Asia Pacific Vascular Injury Treatment Market Attractiveness Analysis, by Treatment, 2019–2027
Figure 56: Asia Pacific Vascular Injury Treatment Market Value Share (%), by End User, 2018 and 2027
Figure 57: Asia Pacific Vascular Injury Treatment Market Attractiveness, by End User, 2019–2027
Figure 58: Latin America Vascular Injury Treatment Market Value (US$ Mn), 2017–2027
Figure 59: Latin America Vascular Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 60: Latin America Vascular Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 61: Latin America Vascular Injury Treatment Market Value Share (%), by Injury, 2018 and 2027
Figure 62: Latin America Vascular Injury Treatment Market Attractiveness, by Injury, 2019–2027
Figure 63: Latin America Vascular Injury Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 64: Latin America Vascular Injury Treatment Market Attractiveness Analysis, by Treatment, 2019–2027
Figure 65: Latin America Vascular Injury Treatment Market Value Share (%), by End User, 2018 and 2027
Figure 66: Latin America Vascular Injury Treatment Market Attractiveness, by End User, 2019–2027
Figure 67: Middle East & Africa Vascular Injury Treatment Market Value (US$ Mn), 2017–2027
Figure 68: Middle East & Africa Vascular Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 69: Middle East & Africa Vascular Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 70: Middle East & Africa Vascular Injury Treatment Market Value Share (%), by Injury, 2018 and 2027
Figure 71: Middle East & Africa Vascular Injury Treatment Market Attractiveness, by Injury, 2019–2027
Figure 72: Middle East & Africa Vascular Injury Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
Figure 73: Middle East & Africa Vascular Injury Treatment Market Attractiveness Analysis, by Treatment, 2019–2027
Figure 74: Middle East & Africa Vascular Injury Treatment Market Value Share (%), by End User, 2018 and 2027
Figure 75: Middle East & Africa Vascular Injury Treatment Market Attractiveness, by End User, 2019–2027

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved